Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunocytochemistry [5]
- Other assay [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-20980 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- ZEB2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Due to post-translational modifications, ZEB2 migrates at ~180kDa in SDS-PAGE. A suggested positive control is Jurkat cell lysate. PA5-20980 can be used with blocking peptide PEP-1094.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 1 mg/mL
- Storage
- Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C
Submitted references Potential functions of embryonic cardiac macrophages in angiogenesis, lymphangiogenesis and extracellular matrix remodeling.
Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria.
Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.
Mechanoresponsive stem cells acquire neural crest fate in jaw regeneration.
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Gula G, Rumiński S, Niderla-Bielińska J, Jasińska A, Kiernozek E, Jankowska-Steifer E, Flaht-Zabost A, Ratajska A
Histochemistry and cell biology 2021 Jan;155(1):117-132
Histochemistry and cell biology 2021 Jan;155(1):117-132
Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria.
Nishad R, Meshram P, Singh AK, Reddy GB, Pasupulati AK
BMJ open diabetes research & care 2020 Jun;8(1)
BMJ open diabetes research & care 2020 Jun;8(1)
Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
Nishad R, Mukhi D, Tahaseen SV, Mungamuri SK, Pasupulati AK
The Journal of biological chemistry 2019 Nov 1;294(44):16109-16122
The Journal of biological chemistry 2019 Nov 1;294(44):16109-16122
ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.
DaSilva-Arnold SC, Kuo CY, Davra V, Remache Y, Kim PCW, Fisher JP, Zamudio S, Al-Khan A, Birge RB, Illsley NP
Molecular human reproduction 2019 Feb 1;25(2):61-75
Molecular human reproduction 2019 Feb 1;25(2):61-75
Mechanoresponsive stem cells acquire neural crest fate in jaw regeneration.
Ransom RC, Carter AC, Salhotra A, Leavitt T, Marecic O, Murphy MP, Lopez ML, Wei Y, Marshall CD, Shen EZ, Jones RE, Sharir A, Klein OD, Chan CKF, Wan DC, Chang HY, Longaker MT
Nature 2018 Nov;563(7732):514-521
Nature 2018 Nov;563(7732):514-521
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E, Wang J, Yumoto K, Jung Y, Cackowski FC, Decker AM, Li Y, Franceschi RT, Pienta KJ, Taichman RS
Neoplasia (New York, N.Y.) 2016 Sep;18(9):553-66
Neoplasia (New York, N.Y.) 2016 Sep;18(9):553-66
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of ZEB2 in Jurkat cells with ZEB2 Polyclonal Antibody (Product # PA5-20980) at 20 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of ZEB2 in Jurkat cells with ZEB2 Polyclonal Antibody (Product # PA5-20980) at 20 µg/mL. Red: ZEB2 Blue: DAPI staining
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemistry of ZEB2 in Jurkat cells with ZEB2 Polyclonal Antibody (Product # PA5-20980) at 20 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of ZEB2 in Jurkat cells with ZEB2 Polyclonal Antibody (Product # PA5-20980) at 20 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of ZEB2 in Jurkat cells with ZEB2 Polyclonal Antibody (Product # PA5-20980) at 20 µg/mL. Red: ZEB2 Blue: DAPI staining
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4 Silencing DNMT1 is correlated with EMT induction and stemness in PCa cells. PCa cells (PC3 or DU145) were transiently transfected with siRNA targeting DNMT1 and cultured for 72 hours. (A) mRNA levels of DNMT1 in control or DNMT1-silenced PCa cells (PC3 or DU145) as quantified by real-time PCR. (B) Protein levels of DNMT1 in control or DNMT1-silenced PCa cells (PC3 or DU145) as quantified by Western blots. (C) EMT markers in control or DNMT1-silenced PCa cells (PC3 or DU145) as quantified by Western blots. (D) Migration of DNMT1-silenced PCa cells was performed by chemotaxis assays. (E) CSC populations (CD133 + /CD44 + phenotype) from control or DNMT1-silenced PCa cells (PC3 or DU145) as evaluated by FACS analysis. The data in A, D, and E are representative of mean +- SD ( n = 6). P values were calculated by Student's t test. (F) Stem cell-related transcription factors in control or DNMT1-silenced PCa cells (PC3 or DU145) as quantified by Western blots. (G) PKCalpha in control or DNMT1-silenced PCa cells (PC3 or DU145) as quantified by Western blots. mRNA levels of (H) PKCalpha, (I) Zeb2, and (J) KLF4 expression in control or DNMT1-silenced PCa cells (PC3 or DU145) with the presence or absence of a pan-PKC inhibitor for 3 days as quantified by real-time PCR. The data in H, I, and J are representative of mean +- SD ( n = 3). P values were calculated by Student's t test. Figure 4
